However, TGFB signaling orchestrates the EMT, and cancer cells use TGFB to create an immune-suppressive tumor microenvironment (TME), which suppresses the antitumor immune reactions that foster tumor progression and metastasis (1, 2, 5, 9, 12–15). Here, TGFB1 is linked to neoplasm.